Showing results (1081-1090 of 1,096) with videos related to
Sort By:
Pageof 110
Child Abuse & Neglect|January 12, 2013
Exploring child maltreatment and its relationship to alcohol and cannabis use in selected Latin American and Caribbean countriesS Longman-Mills, W Y González, M O Meléndez, et al.JAMA Cardiology|March 25, 2026
Oral Semaglutide and Change in Cardiovascular Risk Factors in High-Risk Type 2 Diabetes: A Post Hoc Secondary Analysis of the SOUL Randomized Clinical TrialSharon L Mulvagh, Silvio E Inzucchi, Nikolaus Marx, et al.Lancet (London, England)|May 25, 2016
Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studiesAndrew Mente, Martin O'Donnell, Sumathy Rangarajan, et al.Diabetes Care|December 11, 2025
Impact of Oral Semaglutide on Kidney Outcomes in People With Type 2 Diabetes: Results From the SOUL Randomized TrialJohannes F E Mann, Nikolaus Marx, John E Deanfield, et al.Circulation|March 29, 2025
Oral Semaglutide and Cardiovascular Outcomes in People With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized TrialNikolaus Marx, John E Deanfield, Johannes F E Mann, et al.JAMA Internal Medicine|February 2, 2026
Oral Semaglutide and Heart Failure Outcomes in Persons With Type 2 Diabetes: A Secondary Analysis of the SOUL Randomized Clinical TrialRodica Pop-Busui, Søren Rasmussen, John E Deanfield, et al.Journal of Nephrology|March 13, 2021
Nomenclature in nephrology: preserving 'renal' and 'nephro' in the glossary of kidney health and diseaseKamyar Kalantar-Zadeh, Peter A McCullough, Sanjay Kumar Agarwal, et al.Nucleic Acids Research|December 8, 2025
Mechanistic insights into the monotherapy and combination potential of FEN1 inhibition in cancer therapyEeson Rajendra, Claudio A Lademann, Bethany Mason, et al.Journal of Medicinal Chemistry|December 8, 2025
Discovery of ART5537: A Potent and Selective Small-Molecule Probe for EXO1Sam E Mann, Owen A Davis, Jörg Bomke, et al.Oral Oncology|November 2, 2022
Prognostic value of CD103<sup>+</sup> tumor-infiltrating lymphocytes and programmed death ligand-1 (PD-L1) combined positive score in recurrent laryngeal squamous cell carcinomaJoshua D Smith, Emily L Bellile, Susan E Ellsperman, et al.Pageof 110